Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EXOZ stock hub

eXoZymes, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EXOZis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

81.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

EXOZ

In the news

Latest news · EXOZ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-132.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-73.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EXOZ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

159

Groups with data

Currency

USD

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002010788
Company name	eXoZymes, Inc.
Country	United States
Country code	US
Cusip	461874109
Employees	32
Employees Change	1%
Employees Change Percent	3.23
Enterprise value	$79.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US4618741098
Last refreshed	2026-05-10
Market cap	$81.6M
Market cap category	Micro-Cap
Price	$9.62
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	EXOZ
Website	https://www.exozymes.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.23%
FCF yield	-8.18%
P/B ratio	23.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-9.2M
Net Income Growth Years	0%
Profit Per Employee	$-286,210
ROA	-63.9
ROCE	-220.6
ROE	-132.6
ROIC	-73.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-12.55%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$6M
Cash	$3M
Current Assets	$3.9M
Current Liabilities	$1.6M
Debt	$1.2M
Debt Equity	$0.37
Equity	$3.4M
Liabilities	$2.6M
Long Term Assets	$2M
Long Term Liabilities	$1M
Net Cash	$1.8M
Net Cash By Market Cap	$2.2
Net Cash Growth	-78.44%
Net Debt Equity	$-0.53
Tangible Book Value	$3.4M
Tangible Book Value Per Share	$0.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.51
Net Working Capital	$-340,422
Quick ratio	2.27
Working Capital	$2.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-27.7%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-12.55%
200-day SMA	11.15
50-day SMA	8.94
50-day SMA vs 200-day SMA	50under200
All Time High	23.99
All Time High Change	-59.9%
All Time High Date	2025-02-13
All Time Low	7.08
All Time Low Change	35.88%
All Time Low Date	2026-03-04
ATR	0.58
Beta1y	1.45
Beta2y	1.3
Ch YTD	-11.74
High	9.62
High52	18.4
High52 Date	2025-11-10
High52ch	-47.72%
Low	9.5
Low52	7.08
Low52 Date	2026-03-04
Low52ch	35.88%
Ma50ch	7.61%
Price vs 200-day SMA	-13.71%
RSI	46.34
RSI Monthly	45.44
RSI Weekly	46.67
Sharpe ratio	0.3x
Sortino ratio	0.55
Total Return	-27.7%
Tr YTD	-11.74
Tr1m	-3.9%
Tr1w	-1.33%
Tr3m	-8.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-9.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,319,885%
Float Percent	74.54%
Net Borrowing	-27,709
Shares Insiders	25.46%
Shares Institutions	47.13%
Shares Out	8,478,992
Shares Qo Q	0.07%
Shares Yo Y	27.7%
Short Float	0.18%
Short Ratio	1.63
Short Shares	0.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-8.7M
Average Volume	5,235.65x
Bv Per Share	0.4
CAPEX	$-169,917
Ch1m	-3.9
Ch1w	-1.33
Ch1y	-12.55
Ch3m	-8.47
Ch6m	-31.29
Change	-3.8%
Change From Open	1.26
Close	10
Days Gap	-5
Depreciation Amortization	287,961
Dollar Volume	38,852.6
Earnings Date	2026-03-31
Earnings Time	amc
EBIT	$-9.7M
EBITDA	$-9.4M
EPS	$-1.09
F Score	1
FCF	$-6.7M
FCF EV Yield	-8.36x
FCF Per Share	$-0.79
Financing CF	-27,709
Fiscal Year End	December
Founded	2,014
Income Tax	$-105,205
Investing CF	-150,218
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-30
Ma150	11.4
Ma150ch	-15.58%
Ma20	10.45
Ma20ch	-7.97%
Net CF	-6,679,967
Next Earnings Date	2026-07-01
Open	9.5
Optionable	No
Position In Range	100
Post Close	9.62
Postmarket Change Percent	-1.98
Postmarket Price	$9.43
Ppne	1,926,724
Price Date	2026-05-08
Ptbv Ratio	24.01
Relative Volume	0.77x
Share Based Comp	1,988,105
Tr6m	-31.29%
Us State	California
Volume	4,038.7

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EXOZ pay a dividend?

Capital-return profile for this ticker.

Performance

EXOZ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EXOZ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+47.1%

Float: +74.5% of shares outstanding

Insider ownership

+25.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

EXOZ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.3

Neutral momentum band

Price vs 200-day MA

-13.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EXOZ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current EXOZ stock rating?

eXoZymes, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EXOZ analysis?

The full report lives at /stocks/EXOZ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for EXOZ?

The latest report frames EXOZ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the EXOZ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.